Working with TipRanks
Follow Us
Research Tools
Calendars
Calculators
Education
About Us
Working with TipRanks
Follow Us
ADC Therapeutics Ltd (ADCT)
NYSE:ADCT
ADC Therapeutics (ADCT) Stock Price & Analysis
162 Followers
ADCT Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$0.68 - $5.75
Previous Close$0.82
Volume96.08K
Average Volume (3M)476.13K
Market Cap
$66.47M
Enterprise Value$42.97M
Total Cash (Recent Filing)$31.15M
Total Debt (Recent Filing)$7.66M
Price to Earnings (P/E)-0.4
Beta1.34
Next Earnings
Nov 16, 2023EPS Estimate
-$0.61Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-2.26
Shares Outstanding80,642,530
10 Day Avg. Volume251,608
30 Day Avg. Volume476,125
Standard Deviation0.19
R-Squared0.08
Alpha-0.08
Financial Highlights & Ratios
Price to Book (P/B)-0.75
Price to Sales (P/S)0.32
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue0.31
Enterprise Value/Gross Profit0.21
Enterprise Value/Ebitda-0.42
Forecast
1Y Price Target
$5.10Price Target Upside519.01% Upside
Rating ConsensusHold
Number of Analyst Covering5
ADC Therapeutics News
Risk Analysis
Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products
Product Insights
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
ADCT FAQ
What was ADC Therapeutics Ltd’s price range in the past 12 months?
ADC Therapeutics Ltd lowest stock price was $0.68 and its highest was $5.75 in the past 12 months.
What is ADC Therapeutics Ltd’s market cap?
Currently, no data Available
When is ADC Therapeutics Ltd’s upcoming earnings report date?
ADC Therapeutics Ltd’s upcoming earnings report date is Nov 16, 2023 which is in 43 days.
How were ADC Therapeutics Ltd’s earnings last quarter?
ADC Therapeutics Ltd released its earnings results on Aug 08, 2023. The company reported -$0.58 earnings per share for the quarter, beating the consensus estimate of -$0.7 by $0.12.
Is ADC Therapeutics Ltd overvalued?
According to Wall Street analysts ADC Therapeutics Ltd’s price is currently Undervalued.
Does ADC Therapeutics Ltd pay dividends?
ADC Therapeutics Ltd does not currently pay dividends.
What is ADC Therapeutics Ltd’s EPS estimate?
ADC Therapeutics Ltd’s EPS estimate is -$0.61.
How many shares outstanding does ADC Therapeutics Ltd have?
ADC Therapeutics Ltd has 80,642,525 shares outstanding.
What happened to ADC Therapeutics Ltd’s price movement after its last earnings report?
ADC Therapeutics Ltd reported an EPS of -$0.58 in its last earnings report, beating expectations of -$0.7. Following the earnings report the stock price went up 11.888%.
Which hedge fund is a major shareholder of ADC Therapeutics Ltd?
Among the largest hedge funds holding ADC Therapeutics Ltd’s share is Perceptive Advisors LLC. It holds ADC Therapeutics Ltd’s shares valued at N/A.
---
ADC Therapeutics Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Hold
Average Price Target:
$5.10 (519.01% Upside)
$5.10 (519.01% Upside)
Hedge Fund Trend
Decreased
By 1.6M Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Very Negative
Last 7 Days ▼ 0.9%
Last 30 Days ▼ 4.0%
Last 30 Days ▼ 4.0%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-83.02%
12-Months-Change
Fundamentals
Return on Equity
-339.66%
Trailing 12-Months
Asset Growth
-2.53%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
ADC Therapeutics Ltd
ADC Therapeutics SA is a United States-based clinical-stage oncology-focused biotechnology company. It is involved in the development of antibody-drug conjugates for patients suffering from hematological malignancies and solid tumors. The company's product candidate includes ADCT-402, ADCT-301, ADCT-602, and ADCT-601.
---
Top 5 ETFs holding ADCT
Currently, no data available
Please return soon. This page is being updated.
Up to five ETFs with an Outperform Smart Score that hold ADCT. The ETFs are listed according to market value of ADCT within the ETF
Advaxis
―
Adverum Biotechnologies
―
Adaptimmune Therapeutics
―
Adaptive Biotechnologies
―
---